المؤلفون: Ibne Rasa SM; Lahore Medical and Dental College, Lahore, Pakistan., Ahmad D; Lahore Medical and Dental College, Lahore, Pakistan., Hasan M; Lahore Medical and Dental College, Lahore, Pakistan., Raza Khan AH; Azra Naheed Medical College, Lahore, Pakistan., Farhan M; Lahore Medical and Dental College, Lahore, Pakistan., Effan F; Lahore Medical and Dental College, Lahore, Pakistan.

المصدر: JPMA. The Journal of the Pakistan Medical Association [J Pak Med Assoc] 2024 Jul; Vol. 74 (7), pp. 1325-1329.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pakistan Medical Association Country of Publication: Pakistan NLM ID: 7501162 Publication Model: Print Cited Medium: Internet ISSN: 0030-9982 (Print) Linking ISSN: 00309982 NLM ISO Abbreviation: J Pak Med Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Health Knowledge, Attitudes, Practice* , Genetic Predisposition to Disease* , Genes, BRCA1*, Humans ; Female ; Pakistan ; Male ; Adult ; Young Adult ; Breast Neoplasms/genetics ; Genes, BRCA2 ; Surveys and Questionnaires ; Educational Status ; Mutation ; Adolescent ; Genetic Testing

المؤلفون: Narod SA; Women's College Research Institute, Toronto, Ontario, Canada.

المصدر: JAMA [JAMA] 2024 Apr 09; Vol. 331 (14), pp. 1233-1234.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Breast Neoplasms*/surgery , Genes, BRCA1* , Genes, BRCA2* , Pregnancy Complications, Neoplastic*/genetics , Pregnancy Complications, Neoplastic*/mortality , Pregnancy Complications, Neoplastic*/surgery, Female ; Humans ; Pregnancy ; Age Factors ; Heterozygote ; Survival Analysis

المؤلفون: Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy.

المصدر: JAMA [JAMA] 2024 Apr 09; Vol. 331 (14), pp. 1234.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Breast Neoplasms*/surgery , Genes, BRCA2* , Genes, BRCA1* , Pregnancy Complications, Neoplastic*/genetics , Pregnancy Complications, Neoplastic*/mortality , Pregnancy Complications, Neoplastic*/surgery, Female ; Humans ; Pregnancy ; Heterozygote ; Ovariectomy ; Salpingectomy ; Adult ; Middle Aged ; Survival Analysis ; Time Factors ; Risk

المؤلفون: Park SS; Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.; Women's College Research Institute, Women's College Hospital, Toronto, Canada., Zaman T; Women's College Research Institute, Women's College Hospital, Toronto, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada., Kim SJ; Women's College Research Institute, Women's College Hospital, Toronto, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada., Brooks JD; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada., Wong AKO; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Joint Department of Medical Imaging, University Health Network, Toronto, Canada.; Osteoporosis Program, Schroeder Arthritis Institute, University Health Network, Toronto, Canada., Lubiński J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.; Read-Gene S.A., Grzepnica, Poland., Narod SA; Women's College Research Institute, Women's College Hospital, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada., Salmena L; Women's College Research Institute, Women's College Hospital, Toronto, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Kotsopoulos J; Women's College Research Institute, Women's College Hospital, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Feb 06; Vol. 33 (2), pp. 298-305.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA1* , Osteoprotegerin*/genetics, Adult ; Female ; Humans ; BRCA1 Protein/genetics ; Longitudinal Studies ; Smoking

المؤلفون: Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Agostinetto E; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Hamy AS; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Di Meglio A; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel., Hilbers F; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, Barcelona, Spain., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Ignatiadis M; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Moore HCF; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France., Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology (IRCCS), Milan, Italy., Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France., Ferrari A; Hereditary Breast and Ovarian Cancer Unit and General Surgery 3-Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, and University of Pavia, Pavia, Italy., Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, and Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; UO Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada., Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, AIRC Institute of Molecular Oncology, Milan, Italy., Ruddy KJ; Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche, e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute, and Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Department of Medical Oncology, Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut., Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico., De Marchis L; Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.; Division of Oncology, Department of Hematology, Oncology, and Dermatology, Umberto 1 University Hospital, Rome, Italy., Del Mastro L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Avano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy., Del Pilar Estevez-Diz M; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Rodriguez-Wallberg KA; Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institute, Stockholm, Sweden.; Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden., Mrinakova B; First Department of Oncology, Comenius University and St Elisabeth Cancer Institute, Bratislava, Slovakia., Meister S; Department of Obstetrics and Gynecology, Ludwig Maximilian University (LMU) Hospital, LMU Munich, Germany., Livraghi L; Department of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy., Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Yerushalmi R; Department of Medical Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Tel Aviv University, Tel Aviv, Israel., De Angelis C; Department of Medical Oncology, University of Naples Federico II, Napoli, Italy., Sánchez-Bayona R; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Meattini I; Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, and Radiation Oncology Unit, Oncology Department, Florence University Hospital, Florence, Italy., Cichowska-Cwalinska N; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Early Phase Clinical Trials Centre, Medical University of Gdańsk, Gdańsk, Poland., Berlière M; Department of Medical Oncology and Breast Surgery, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Belgium., Salama M; Oncofertility Consortium and Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, East Lansing., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy., Sonnenblick A; Oncology Division, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Chiodi C; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Lee YJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Maria C; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.; Cairo Oncology Center, Cairo, Egypt., Boni L; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

مؤلفون مشاركون: BRCA BCY Collaboration

المصدر: JAMA [JAMA] 2024 Jan 02; Vol. 331 (1), pp. 49-59.

نوع المنشور: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Genes, BRCA2* , Genes, BRCA1* , Pregnancy Outcome* , Pregnancy Complications, Neoplastic*/genetics , Pregnancy Complications, Neoplastic*/mortality, Adult ; Female ; Humans ; Pregnancy ; Disease-Free Survival ; Germ-Line Mutation ; Retrospective Studies ; Internationality

المؤلفون: Nikmanesh A; Department of Animal Science, Faculty of Agriculture, Shahid Bahonar University of Kerman, Kerman, Iran., Esmailizadeh A; Department of Animal Science, Faculty of Agriculture, Shahid Bahonar University of Kerman, Kerman, Iran., Asadollahpour Nanaei H; Department of Animal Science, Faculty of Agriculture, Shahid Bahonar University of Kerman, Kerman, Iran., Ezedinloo L; Department of Environment (DOE), Natural History Museum & Genetic Resource, Bureau, Park Nature of Pardisan, Tehran, Iran., Asadi Fozi M; Department of Animal Science, Faculty of Agriculture, Shahid Bahonar University of Kerman, Kerman, Iran.

المصدر: Animal biotechnology [Anim Biotechnol] 2023 Dec; Vol. 34 (9), pp. 4746-4759. Date of Electronic Publication: 2023 Mar 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9011409 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2378 (Electronic) Linking ISSN: 10495398 NLM ISO Abbreviation: Anim Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Variation*/genetics , Genes, BRCA1*, Sheep/genetics ; Animals ; Phylogeny ; Sheep, Domestic/genetics ; Haplotypes/genetics ; Nucleotides

المؤلفون: Fishchuk L; State Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine., Lobanova O; Bogomolets National Medical University, Kyiv 01601, Ukraine., Rossokha Z; State Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine.; Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv 03143, Ukraine., Cheshuk V; Bogomolets National Medical University, Kyiv 01601, Ukraine., Vereshchako R; Bogomolets National Medical University, Kyiv 01601, Ukraine., Vagyn Y; Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv 03143, Ukraine., Kashuba V; Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv 03143, Ukraine., Vershyhora V; State Institution «Reference-center for Molecular Diagnostic of Public Health Ministry of Ukraine», Kyiv 04112, Ukraine., Popova O; State Institution «Reference-center for Molecular Diagnostic of Public Health Ministry of Ukraine», Kyiv 04112, Ukraine., Levkovich N; State Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine., Zemlianska O; State Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine., Ievseienkova O; State Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine., Podolska S; State Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine., Gorovenko N; State Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine.

المصدر: Experimental oncology [Exp Oncol] 2023 Oct 11; Vol. 45 (2), pp. 161-169. Date of Electronic Publication: 2023 Oct 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Akademperiodyka Country of Publication: Ukraine NLM ID: 101230541 Publication Model: Electronic Cited Medium: Internet ISSN: 2312-8852 (Electronic) Linking ISSN: 18129269 NLM ISO Abbreviation: Exp Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA1* , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics, Humans ; Female ; Clinical Relevance ; Promoter Regions, Genetic/genetics ; DNA Methylation ; Genetic Predisposition to Disease ; BRCA1 Protein/genetics

المؤلفون: Machaj F; Independent Clinical Epigenetics Laboratory, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland., Sokolowska KE; Independent Clinical Epigenetics Laboratory, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland., Borowski K; Independent Clinical Epigenetics Laboratory, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland., Retfiński S; Independent Clinical Epigenetics Laboratory, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland., Strapagiel D; Biobank Laboratory, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 139, 90-237, Lodz, Poland., Sobalska-Kwapis M; Biobank Laboratory, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 139, 90-237, Lodz, Poland., Huzarski T; Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland., Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland., Wojdacz TK; Independent Clinical Epigenetics Laboratory, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland. tomasz.wojdacz@pum.edu.pl.

المصدر: Scientific reports [Sci Rep] 2023 Sep 26; Vol. 13 (1), pp. 16102. Date of Electronic Publication: 2023 Sep 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA1* , Labor, Obstetric*, Female ; Humans ; Pregnancy ; Research Design ; Genetic Profile ; Health Status ; BRCA1 Protein/genetics

المؤلفون: Marchetti C; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy., Ataseven B; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Nordrhein-Westfalen, Germany., Perrone AM; Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Cassani C; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS San Matteo Foundation, Pavia, Italy., Fruscio R; Department of Medicine and Surgery, University of Milan - Bicocca, Italy., Sassu CM; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy., Apostol AI; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy., Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Nordrhein-Westfalen, Germany., De Iaco P; Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Camnasio CA; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS San Matteo Foundation, Pavia, Italy., Moubarak M; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Nordrhein-Westfalen, Germany., Giannarelli D; Facility of Epidemiology and Biostatistics - GSTeP, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Scambia G; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: giovanni.scambia@policlinicogemelli.it., Fagotti A; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 170-177. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/mortality , Ovarian Neoplasms*/therapy , Mutation* , Neoplasm Staging* , Cystadenocarcinoma, Serous*/genetics , Cystadenocarcinoma, Serous*/pathology , Cystadenocarcinoma, Serous*/mortality , Cystadenocarcinoma, Serous*/therapy, Humans ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; BRCA1 Protein/genetics ; Neoplasm Grading ; Aged, 80 and over ; BRCA2 Protein/genetics ; Genes, BRCA1 ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Genes, BRCA2 ; Progression-Free Survival ; Prognosis

المؤلفون: Stroot IAS; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands. Electronic address: i.a.s.stroot@umcg.nl., Bart J; University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, the Netherlands., Hollema H; University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, the Netherlands., Jalving M; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, the Netherlands., Wagner MM; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands., Yigit R; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands., van Doorn HC; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Gynecologic Oncology, Rotterdam, the Netherlands., de Hullu JA; Radboud University Medical Center, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., Gaarenstroom KN; Leiden University Medical Center, Department of Obstetrics and Gynecology, Leiden, the Netherlands., van Beurden M; Antoni van Leeuwenhoek, Department of Gynecology, Amsterdam, the Netherlands., van Lonkhuijzen LRCW; Amsterdam University Medical Center-Center for Gynecological Oncology Amsterdam, Department of Gynecologic Oncology, Amsterdam, the Netherlands., Slangen BFM; Maastricht University Medical Center, Department of Gynecology, Maastricht, the Netherlands., Zweemer RP; University Medical Center Utrecht, Department of Gynecologic Oncology, Utrecht, the Netherlands., Gómez García EB; University Medical Center Maastricht, Department of Clinical Genetics, Maastricht, the Netherlands., Ausems MGEM; University Medical Center Utrecht, Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, Utrecht, the Netherlands., Boere IA; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., van Hest LP; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Human Genetics, Amsterdam, the Netherlands., Duijkers FAM; Amsterdam UMC, University of Amsterdam, Department of Human Genetics, Amsterdam, the Netherlands., van Asperen CJ; Leiden University Medical Center, Department of Human Genetics & Department of Pathology, Leiden, the Netherlands., Schmidt MK; Leiden University Medical Center, Department of Human Genetics & Department of Pathology, Leiden, the Netherlands; Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, the Netherlands; Netherlands Cancer Institute, Division of Molecular Pathology, Amsterdam, the Netherlands., Wevers MR; Radboud University Medical Center, Department of Clinical Genetics, Nijmegen, the Netherlands., Ruijs MWG; Netherlands Cancer Institute, Department of Clinical Genetics, Amsterdam, the Netherlands., Devilee P; Leiden University Medical Center, Department of Human Genetics & Department of Pathology, Leiden, the Netherlands., Collée JM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, the Netherlands., Hebon Investigators; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating Center: Netherlands Cancer Institute, Amsterdam, the Netherlands., de Bock GH; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands., Mourits MJE; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 198-203. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Salpingo-oophorectomy* , Germ-Line Mutation* , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/surgery , Cystadenocarcinoma, Serous*/genetics , Cystadenocarcinoma, Serous*/pathology , Cystadenocarcinoma, Serous*/surgery, Humans ; Female ; Middle Aged ; Adult ; Aged ; BRCA2 Protein/genetics ; BRCA1 Protein/genetics ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/prevention & control ; Genes, BRCA2 ; Disease-Free Survival ; Genes, BRCA1 ; Heterozygote ; Neoplasm Grading